Alexander Thiel Selected Research

Neoplasms (Cancer)

1/2019	Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.
1/2019	First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases.
1/2017	A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.
2/2015	Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.
4/2005	Imaging in neurooncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Thiel Research Topics

Disease

18	Stroke (Strokes) 01/2022 - 01/2003
9	Aphasia (Dysphasia) 01/2022 - 08/2005
8	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 11/2016
5	Infarction (Infarctions) 01/2022 - 08/2004
5	Neoplasms (Cancer) 01/2019 - 04/2005
5	Ischemic Stroke 04/2015 - 01/2003
4	Cognitive Dysfunction 01/2023 - 09/2014
3	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 06/2017
3	Dementia (Dementias) 03/2024 - 01/2017
3	Brain Neoplasms (Brain Tumor) 07/2006 - 01/2005
2	Atrophy 04/2024 - 01/2023
2	Mixed Dementias 04/2024 - 11/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2019
2	Leukoencephalopathies 06/2020 - 10/2019
2	Transient Ischemic Attack 06/2020 - 10/2019
2	Lacunar Stroke 06/2020 - 10/2019
2	Anomia (Dysnomia) 01/2019 - 06/2017
2	Ischemia 01/2017 - 01/2016
2	Neuroinflammatory Diseases 09/2014 - 12/2009
1	Cerebral Small Vessel Diseases 04/2024
1	Infections 01/2022
1	COVID-19 01/2022
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022
1	Hypertension (High Blood Pressure) 10/2021
1	Pain (Aches) 01/2020
1	Carcinogenesis 01/2019
1	Fibromyalgia (Fibrositis) 01/2017
1	Cerebral Cortical Thinning 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Nervous System Diseases (Neurological Disorders) 02/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2009
1	Mental Disorders (Mental Disorder) 10/2009
1	Stiff-Person Syndrome (Stiff Man Syndrome) 09/2008
1	Residual Neoplasm 04/2005
1	Glioma (Gliomas) 04/2005
1	Cerebral Hemorrhage 01/2003
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2003

Drug/Important Bio-Agent (IBA)

6	Amyloid (Amyloid Fibrils)IBA 04/2024 - 09/2014
6	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2013
5	Flumazenil (Romazicon)FDA LinkGeneric 01/2020 - 08/2004
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2011
2	Amyloid beta-PeptidesIBA 04/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 11/2016
2	florbetapirIBA 06/2020 - 10/2019
2	Phosphotransferases (Kinase)IBA 01/2017 - 02/2015
2	TropomyosinIBA 01/2017 - 02/2015
2	gamma-Aminobutyric Acid (GABA)IBA 10/2009 - 09/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 10/2009 - 09/2008
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2024
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 10/2021
1	Polyvinyl Chloride (PVC)IBA 01/2017
1	fluoromisonidazoleIBA 01/2016
1	Vasoconstrictor AgentsIBA 01/2016
1	Endothelin-1 (Endothelin 1)IBA 01/2016
1	N 30IBA 11/2015
1	compound 18IBA 02/2015
1	Staphylococcal Protein A (Protein A)IBA 02/2011
1	Indicators and Reagents (Reagents)IBA 12/2009
1	SolutionsIBA 10/2009
1	AntibodiesIBA 09/2008
1	EnzymesIBA 09/2008
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2008
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2003
1	Heparin (Liquaemin)FDA LinkGeneric 01/2003

Therapy/Procedure

11	Transcranial Magnetic Stimulation 01/2022 - 01/2005
9	Therapeutics 01/2022 - 01/2003
5	Language Therapy (Language Training) 01/2022 - 01/2013
5	Transcranial Direct Current Stimulation 01/2021 - 04/2015
3	Aftercare (After-Treatment) 11/2015 - 04/2005
2	Stroke Rehabilitation 01/2022 - 01/2018
1	Exercise Therapy (Therapy, Exercise) 01/2022
1	Speech Therapy (Therapy, Speech) 12/2020
1	Injections 01/2016
1	Adjuvant Chemotherapy 05/2003